Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699982 · ClinicalTrials.gov registry record · NA
Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study
A NA study, sponsored by CAMC Health System.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03699982: Clinical Trial NA study, sponsored by CAMC Health System.
NCT03699982 is a NA study that was terminated before completion, run by CAMC Health System. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03699982, a NA study, was terminated before completion, sponsored by CAMC Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Cystic fibrosis is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body. Individuals with cystic fibrosis often have poor weight gain and growth that can negatively impact health further by worsening lung function. Additionally, persons with the disease typically need more than the usual calories on a daily basis. Most institutions estimate these patients' caloric needs using weight, age, and sex based mathematical formulae. However, numerous studies show that use of these formulae often yields inaccurate caloric values. Use of indirect calorimetry may give more accurate estimates of caloric needs in patients with cystic fibrosis. The aim of our study is to assess the accuracy of caloric estimates generated using one such widely used mathematical formula, the Harris-Benedict equation, and to compare this calorie value with that obtained from indirect calorimetry testing in pediatric and adult patients with cystic fibrosis. Study investigators will use the newly calculated caloric requirements in dietary counseling. Changes in weight and lung function after 3 months will be compared to participants' historical changes.
Primary Outcome
Resting energy expenditure will be obtained using indirect calorimetry and the Harris-Benedict Equation.
Interventions
- OTHER Daily calorie target based on resting energy expenditure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2020-01-20 |
| Phase | NA |
Why NCT03699982 stopped before completion
NCT03699982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Daily calorie target based on resting energy expenditure is the first listed.
NCT03699982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03699982 about?
NCT03699982 is a clinical study titled "Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study". Cystic fibrosis is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body. Individuals with cystic fibrosis often have poor weight gain and growth that can negatively impact health further by worsening lung function. Additionally, persons with th...
What is the current status of trial NCT03699982?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-10-10. Estimated completion is 2020-01-20.
What interventions are being tested in trial NCT03699982?
The interventions under investigation include: Daily calorie target based on resting energy expenditure (OTHER).
Who is sponsoring clinical trial NCT03699982?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03699982's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI